Alvotech Files Form 6-K with SEC

Ticker: ALVOW · Form: 6-K · Filed: Jun 18, 2024 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateJun 18, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-k, foreign-private-issuer

TL;DR

Alvotech filed a 6-K, confirming it's a foreign private issuer reporting under 20-F. Standard disclosure.

AI Summary

Alvotech, a biopharmaceutical company, filed a Form 6-K on June 18, 2024. This filing is a report of a foreign private issuer and indicates that Alvotech files its annual reports under cover of Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

Why It Matters

This filing provides routine disclosure for a foreign private issuer, informing investors about the company's reporting status and principal place of business.

Risk Assessment

Risk Level: low — This filing is a routine administrative report and does not contain material non-public information that would typically impact risk.

Key Players & Entities

  • Alvotech (company) — Registrant
  • 001-41421 (company) — SEC File Number
  • 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg (company) — Principal executive office address

FAQ

What type of filing is this Form 6-K?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What is Alvotech's SEC file number?

Alvotech's SEC file number is 001-41421.

Does Alvotech file annual reports under Form 20-F or 40-F?

Alvotech indicates it files annual reports under cover of Form 20-F.

Where is Alvotech's principal executive office located?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

What is the filing date of this Form 6-K?

This Form 6-K was filed on June 18, 2024.

Filing Stats: 338 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-06-18 06:00:14

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: June 18, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.